Categories: CancerNews

RaySearch’s CEO sells shares – remains a long-term shareholder

STOCKHOLM, Sept. 27, 2024 /PRNewswire/ — RaySearch’s founder and CEO, Johan Löf, has sold 150,000 Class B shares in RaySearch Laboratories AB (publ) on September 24, 2024. Johan Löf remains a long-term shareholder and after the transaction owns 5,443,084 Class A shares and 68,393 Class B shares, corresponding to 16.1 percent of the total number of shares and 52.8 percent of the total number of votes in the company.

Johan Löf, founder and CEO, RaySearch: “The sale is due to private financial reasons. I remain committed to the company with continued strong confidence in RaySearch’s future. We are well positioned for continued growth, and I look forward to continuing to lead and develop RaySearch towards our strategic goals.”

The transaction has been reported to the Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations.

ABOUT RAYSEARCH

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems. 

RaySearch’s software has been sold to over 1,000 clinics in 43 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.

* Subject to regulatory clearance in some markets. 

FOR MORE INFORMATION, PLEASE CONTACT:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00 
johan.lof@raysearchlabs.com

Learn more about us on:
LinkedIn
YouTube
X

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/raysearch-laboratories/r/raysearch-s-ceo-sells-shares—remains-a-long-term-shareholder,c4044028

The following files are available for download:

https://mb.cision.com/Main/1102/4044028/3027561.pdf

RaySearch Press Release, September 27, 2024_

 

View original content:https://www.prnewswire.com/news-releases/raysearchs-ceo-sells-shares–remains-a-long-term-shareholder-302261179.html

SOURCE RaySearch Laboratories

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

20 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

20 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago